Bone-Seeking Probes for Optical and Magnetic Resonance Imaging

• Fleisch H . Bisphosphonates in Bone Disease. Academic Press, London, UK (2000).
   Google Scholar
• Shea JE , MillerSC. Skeletal function and structure. implications for tissue-targeted therapeutics.Adv. Drug Deliv. Rev.57, 945–957 (2005).
   PubMed Web of Science ®Google Scholar
• Wang D , MillerSC, KopečkováP, KopečekJ. Bone-targeting macromolecular therapeutics.Adv. Drug Deliv. Rev.57, 1049–1076 (2005).
   PubMed Web of Science ®Google Scholar
• Zhang S , GangalG, UludagH. ‘Magic bullets’ for bone diseases. progress in rational design of boneseeking medicinal agents.Chem. Soc. Rev.36, 507–531 (2007).
   PubMed Web of Science ®Google Scholar
• Russell RGG . Bisphosphonates: mode of action and pharmacology.Pediatrics119, S150–S162 (2007).
   PubMed Web of Science ®Google Scholar
• Marczewski AW , JaroniecM. A new isotherm equation for single-solute adsorption from dilute solutions on energetically heterogeneous solids.Monatsh. Chem.114(6-7), 711–715 (1983).
   Web of Science ®Google Scholar
• Jaroniec M , DeryloA, MarczewskiAW. The Langmuir–Freundlich equation in adsorption from dilute solutions on solids.Monatsh. Chem.114(4), 393–397 (1983).
   Web of Science ®Google Scholar
• Mukherjee S , SongY, OldfieldE. NMR investigations of the static and dynamic structures of bisphosphonates on human bone: a molecular model.J. Am. Chem. Soc.130(4), 1264–1273 (2008).
   PubMed Web of Science ®Google Scholar
• Kubíček V , RudovskýJ, KotekJet al. A bisphosphonate monoamide analogue of DOTA. a potential agent for bone targeting. J. Am. Chem. Soc. 127, 16477–16485 (2005).
   PubMed Web of Science ®Google Scholar
• Vitha T , KubíčekV, HermannPet al. Lanthanide(III) complexes of bis(Phosphonate) monoamide analogues of DOTA. bone-seeking agents for imaging and therapy. J. Med. Chem. 51, 677–683 (2008).
   PubMed Web of Science ®Google Scholar
• Vitha T , KubíčekV, KotekJet al. A Gd(III) complex of a monophosphinate-bis(Phosphonate) DOTA analogue with a high 1H NMR relaxivity; lanthanide(III) complexes for imaging and radiotherapy of calcified tissues. Dalton Trans. 3201–3214 (2009).
   Web of Science ®Google Scholar
• Vitha T , KubíčekV, HermannPet al. Complexes of DOTA-bisphosphonate conjugates. probes for determination of adsorption capacity and affinity constants of hydroxyapatite. Langmuir 24, 1952–1958 (2008).
   PubMed Web of Science ®Google Scholar
• Rill C h, Kolar ZI, Kickelbick G, Wolterbeek HTH, Peters JA. Kinetics and thermodynamics of adsorption on hydroxyapatite of the [160Tb]terbium complexes of the bone-targeting ligands DOTP and BPPED. Langmuir25(4), 2294–2301 (2009).
   PubMed Web of Science ®Google Scholar
• The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging . MerbachAE, TóthÉ, (Eds). Wiley, Chichester, UK (2001).
   Google Scholar
• Friebolin H . Basic One- and Two-Dimensional NMR Spectroscopy. VCH, Germany (2005).
   Google Scholar
• Aime S , BottaM, TerrenoE. Gd(III)-based contrast agents for MRI.Adv. Inorg. Chem.57, 173-237 (2005).
   Web of Science ®Google Scholar
• Hermann P , KotekJ, KubíčekV, LukešI. Gadolinium(III) complexes as MRI contrast agents. ligand design and properties of the complexes.Dalton Trans.3027–3047 (2008).
   PubMedGoogle Scholar
• Kubíček V , Tóth É. Design and function of metal complexes as contrast agents in MRI. Adv. Inorg. Chem.61, 63–129 (2009).
   Web of Science ®Google Scholar
• Aime S , CabellaC, ColombattoS, CrichSG, GianolioE, MaggioniF. Insights into the use of paramagnetic Gd(III) complexes in MR-molecular imaging investigations.J. Magn. Reson. Imaging16, 394–406 (2002).
   PubMed Web of Science ®Google Scholar
• Langereis S , DirksenA, HackengTM, van Genderen MHP, Meijer EW. Dendrimers and magnetic resonance imaging. New J. Chem.31, 1152–1160 (2007).
   Web of Science ®Google Scholar
• Konda SD , ArefM, WangS, BrechbielM, WienerEC. Specific targeting of folate–dendrimer MRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenografts.Magn. Reson. Mater. Phys. Biol. Med.12, 104–113 (2001).
   Google Scholar
• Wehrli FW , SongHK, SahaPK, WrightAC. Quantitative MRI for the assessment of bone structure and function.NMR Biomed.19, 731–764 (2006).
   PubMed Web of Science ®Google Scholar
• Biswal S , ResnickDL, HoffmanJM, GambhirSS. Molecular imaging: integration of molecular imaging into the musculoskeletal imaging practice.Radiology244(3), 651–671 (2007).
   PubMed Web of Science ®Google Scholar
• Lang P , HondaG, RobertsTet al. Musculoskeletal neoplasm: perineoplastic edema versus tumor on dynamic postcontrast MR images with spatial mapping of instantaneous enhancement rates. Radiology 197, 831–839 (1995).
   PubMed Web of Science ®Google Scholar
• Dangman BC , HofferFA, RandFF, O‘RourkeEJ. Osteomyelitis in children: gadolinium-enhanced MR imaging.Radiology182, 743–747 (1992).
   PubMed Web of Science ®Google Scholar
• Gylys-Morin VM , GrahamTB, BlebeaJSet al. Knee in early juvenile rheumatoid arthritis: MR imaging findings. Radiology 220, 696–706 (2001).
   PubMed Web of Science ®Google Scholar
• Bonnerot V , SebagG, de Montalembert M et al. Gadolinium-DOTA enhanced MRI of painful osseous crises in children with sickle cell anemia. Pediatr. Radiol.24, 92–95 (1994).
   PubMed Web of Science ®Google Scholar
• Bligh SWA , Harding ChT, McEwen AB, Adler PJ. Synthesis, characterisation and comparative study of aminophosphonate chelates of gadolinium(III) ions as magnetic resonance imaging contrast agents. Polyhedron13(12), 1937–1943 (1994).
   Web of Science ®Google Scholar
• Alves CF , DonatoP, SherryADet al. Silencing of phosphonate-gadolinium magnetic resonance imaging contrast by hydroxyapatite binding. Invest. Radiol. 38(12), 750–760 (2003).
   PubMed Web of Science ®Google Scholar
• Adzamli K , BlauM. Phosphonate-modified GdDTPA complexes. I. NMRD study of the solution behavior of new tissue-specific contrast agents.Magnet. Reson. Med.17(1), 141–148 (1991).
   PubMed Web of Science ®Google Scholar
• Adzamli K , BlauM, PfefferMA, DavisMA. Phosphonate-modified Gd-DTPA complexes. III: the detection of myocardial infarction by MRI.Magnet. Reson. Med.29(4), 505–511 (1993).
   PubMed Web of Science ®Google Scholar
• Adzamli K , JohnsonD, BlauM. Phosphonate-modified GdDTPA complexes. II. Evaluation in a rat myocardial infarction model.Invest. Radiol.26(2), 143–148 (1991).
   PubMed Web of Science ®Google Scholar
• Adzamli K , GriesH, JohnsonD, BlauM. Development of phosphonate derivatives of gadolinium chelates for NMR imaging of calcified soft tissues.J. Med. Chem.32, 139–144 (1989).
   PubMed Web of Science ®Google Scholar
• Shu C h-Y, Wang Ch-R, Zhang J-F et al. Organophosphonate functionalized Gd@C82 as a magnetic resonance imaging contrast agent. Chem. Mater.20, 2106–2109 (2008).
   Web of Science ®Google Scholar
• Miller SC , WangD, KopečkováP, KopečekJ. Biopolymer-based delivery systems for advanced imaging and skeletal tissue-specific therapeutics.J. Bone Miner. Metab.23(Suppl.), 103–108 (2005).
   PubMedGoogle Scholar
• Mayer-Kuckuk P , GadeTPF, BuchananIMet al. High-resolution imaging of bone precursor cells within the intact bone marrow cavity of living mice. Mol. Ther. 12(1), 33–41 (2005).
   PubMed Web of Science ®Google Scholar
• Chesnick IE , TodorovTI, CentenoJA, NewburyDE, SmallJA, PotterK. Manganese-enhanced magnetic resonance microscopy of mineralization.Magn. Reson. Imaging25, 1095–1104 (2007).
   PubMed Web of Science ®Google Scholar
• Laurent S , Vander Elst L, Copoix F, Muller RN. Stability of MRI paramagnetic contrast media: a proton relaxometric protocol for transmetallation assessment. Invest. Radiol.36(2), 115–122 (2001).
   PubMed Web of Science ®Google Scholar
• Frangioni JV . In vivo near-infrared fluorescence imaging. Curr. Opin. Chem. Biol.7, 626–634 (2003).
   PubMed Web of Science ®Google Scholar
• Rao J , Dragulescu-AndrasiA, YaoH. Fluorescence imaging in vivo: recent advances. Curr. Opin. Biotech.18, 17–25 (2007).
   PubMed Web of Science ®Google Scholar
• Mitose K , KojimaH, NaganoT. Functional near-infrared fluorescent probes.Chem. Asian J.3, 506–515 (2008).
   Web of Science ®Google Scholar
• Michalet X , PinaudFF, BentolilaLAet al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307, 538–544 (2005).
   PubMed Web of Science ®Google Scholar
• Thibon A , PierreVC. Principles of responsive lanthanide-based luminescent probes for cellular imaging.Anal. Bioanal. Chem.394, 107–120 (2009).
   PubMed Web of Science ®Google Scholar
• Hale LV , MaYF, SanterreRF. Semi-quantitative fluorescence analysis of calcein binding as a measurement of in vitro mineralization. Calcif. Tissue Int.67, 80–84 (2000).
   PubMed Web of Science ®Google Scholar
• Zaheer A , LenkinskiRE, MahmoodA, JonesAG, CantleyLC, FrangioniJV. In vivo near-infrared fluorescence imaging of osteoblastic activity. Nat. Biotechnol.19(12), 1148–1154 (2001).
   PubMed Web of Science ®Google Scholar
• Lenkinski RE , AhmedM, ZaheerA, FrangioniJV, GoldbergSN. Near-infrared fluorescence imaging of microcalcification in an animal model of breast cancer.Acad. Radiol.10(10), 1159–1164 (2003).
   PubMed Web of Science ®Google Scholar
• Zaheer A , MurshedM, De Grand AM, Morgan TG, Karsenty G, Frangioni JV. Optical imaging of hydroxyapatite in the calcified vasculature of transgenic animals. Arterioscler. Thromb. Vasc. Biol.26, 1132–1136 (2006).
   PubMed Web of Science ®Google Scholar
• Bhushan KR , TanakaE, FrangioniJV. Synthesis of conjugatable bisphosphonates for molecular imaging of large animals.Angew. Chem. Int. Ed.46, 7969–7971 (2007).
   PubMed Web of Science ®Google Scholar
• Bhushan KR , MisraP, LiuF, MathurS, LenkinskiRE, FrangioniJV. Detection of breast cancer microcalcifications using a dual-modality SPECT/NIR fluorescent probe.J. Am. Chem. Soc.130(52), 17648–17649 (2008).
   PubMed Web of Science ®Google Scholar
• Kashemirov BA , BalaJLF, ChenXet al. Fluorescently labeled risedronate and related analogues: ‘magic linker’ synthesis. Bioconjugate Chem. 19(12), 2308–2310 (2008).
   PubMed Web of Science ®Google Scholar
• Maalouf MA , WiemerAJ, KuderCH, HohlRJ, WiemerDF. Synthesis of fluorescently tagged isoprenoid bisphosphonates that inhibit protein geranylgeranylation.Bioorg. Med. Chem.15, 1959–1966 (2007).
   PubMed Web of Science ®Google Scholar
• Kozloff KM , WeisslederR, MahmoodU. Noninvasive optical detection of bone mineral.J. Bone Miner. Res.22(8), 1208–1216 (2007).
   PubMed Web of Science ®Google Scholar
• Aikawa E , NahrendorfM, Figueiredo J-L et al. Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation116, 2841–2850 (2007).
   PubMed Web of Science ®Google Scholar
• Zilberman Y , KallaiI, GafniYet al. Fluorescence molecular tomography enables in vivo visualization and quantification of nonunion fracture repair induced by genetically engineered mesenchymal stem cells. J. Orthop. Res. 26, 522–530 (2008).
   PubMed Web of Science ®Google Scholar
• Kozloff KM , QuintiL, PatntirapongSet al. Non-invasive optical detection of cathepsin K-mediated fluorescence reveals osteoclast activity in vitro and in vivo. Bone 44, 190–198 (2009).
   PubMed Web of Science ®Google Scholar
• White GW , GibbyWA, TweedleMF. Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy.Invest. Radiol.41(3), 272–278 (2006).
   PubMed Web of Science ®Google Scholar
• De Leon-Rodriguez LM , LubagAJM, MalloyCR, MartinezGV, GilliesRJ, SherryAD. Responsive MRI agents for sensing metabolism in vivo. Acc. Chem. Res.42(7), 948–957 (2009).
   PubMed Web of Science ®Google Scholar

Website

• Visen. Translational fluorescence in vivo imaging www.visenmedical.com
   Google Scholar